Higher Improvement of Cardiac Function Following Myocardial Infarction using Menstrual Blood Stromal/Stem Cells (MenSCs) Suspended in Conditioned Medium versus Conditioned Medium Alone in Rat Model

To evaluate the efficiency of Menstrual blood Stromal/Stem Cells (MenSCs) administration in Myocardial Infarction (MI), the effects of MenSCs and their derived conditioned Medium (CM) on cardiac function in MI rat model was assessed. Animals were divided into four groups including sham group, MI gro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Avicenna journal of medical biotechnology 2023-07, Vol.15 (3), p.157-166
Hauptverfasser: Manshori, Mahmood, Kazemnejad, Somaieh, Naderi, Nasim, Shirazi, Abolfazl, Arabian, Maedeh, Eghtedar Doost, Marzieh, Darzi, Maryam, Montazeri, Samaneh, Aboutaleb, Nahid, Golshahi, Hannaneh
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 166
container_issue 3
container_start_page 157
container_title Avicenna journal of medical biotechnology
container_volume 15
creator Manshori, Mahmood
Kazemnejad, Somaieh
Naderi, Nasim
Shirazi, Abolfazl
Arabian, Maedeh
Eghtedar Doost, Marzieh
Darzi, Maryam
Montazeri, Samaneh
Aboutaleb, Nahid
Golshahi, Hannaneh
description To evaluate the efficiency of Menstrual blood Stromal/Stem Cells (MenSCs) administration in Myocardial Infarction (MI), the effects of MenSCs and their derived conditioned Medium (CM) on cardiac function in MI rat model was assessed. Animals were divided into four groups including sham group, MI group, MenSCs derived CM group (CM group), and MenSCs suspended in CM (MenSCs+CM) group. The injection of different groups was carried out 30 after ligation of left anterior descending coronary artery into the infarct border zone. The results showed a significant reduction in scar size after injection of MenSCs+CM compared to MI group. Ejection fraction and fractional shortening of MenSCs+CM group were higher than CM and MI group at day 28. Administration of MenSCs+CM led to much more survival of cardiomyocytes, and prevention of meta-plastic development. Moreover, human mitochondrial transfer from MenSCs to cardiomyocytes was seen in group treated by MenSCs+CM. Indeed, MenSCs+CM treatment evoked nuclear factor-κB (NF-κB) down-regulation more than other treatments. MenSCs+CM treatment could significantly ameliorate cardiac function by different mechanisms including inhibition of cartilaginous metaplasia, inhibition of NF-κB and mitochondrial transfer.
doi_str_mv 10.18502/ajmb.v15i3.12924
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10395459</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2846930418</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2674-13bb6f2a0cc020382ee329c4c987f71aa481bec23bf5deb6b384ef5aac1e34bf3</originalsourceid><addsrcrecordid>eNptUstqGzEUHUpLE9J8QDdFy3RhR895rEo61IkhJhC3a6HR3HEUNJIrzbjkA_NfkcdOaKHaSJfzkDg6WfaZ4DkpBaaX6rFv5jsiDJsTWlH-LjulGJcznlPx_nimJRMn2XmMj3i_CiwE-5idsEKwknJ8mj3fmM0DBLTst8HvoAc3IN-hWoXWKI0Wo9OD8Q4tvLX-j3EbtHryekItWrpOhQM-xgkDF4cwJui79b5F6yH4XtnL9QA9qsHaiC4SZ13Hr2g9xi24FlpkHKq9a83eKI0raM3Yox2EOMb_IVc2TXvVvRrQyrdgP2UfOmUjnB_3s-zX4sfP-mZ2e3e9rK9uZ5rmBZ8R1jR5RxXWGlOcEgBgtNJcV2XRFUQpXpIGNGVNJ1po8oaVHDqhlCbAeNOxs-zbwXc7Nj20OqUVlJXbYHoVnqRXRv6LOPMgN34nCWaV4KJKDhdHh-B_jxAH2ZuoUzLKgR-jpCXPK4Y5KROVHKg6-BgDdG_3ECynCsh9BeRUATlVIGm-_P3AN8Xrh7MXOUazew</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2846930418</pqid></control><display><type>article</type><title>Higher Improvement of Cardiac Function Following Myocardial Infarction using Menstrual Blood Stromal/Stem Cells (MenSCs) Suspended in Conditioned Medium versus Conditioned Medium Alone in Rat Model</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Manshori, Mahmood ; Kazemnejad, Somaieh ; Naderi, Nasim ; Shirazi, Abolfazl ; Arabian, Maedeh ; Eghtedar Doost, Marzieh ; Darzi, Maryam ; Montazeri, Samaneh ; Aboutaleb, Nahid ; Golshahi, Hannaneh</creator><creatorcontrib>Manshori, Mahmood ; Kazemnejad, Somaieh ; Naderi, Nasim ; Shirazi, Abolfazl ; Arabian, Maedeh ; Eghtedar Doost, Marzieh ; Darzi, Maryam ; Montazeri, Samaneh ; Aboutaleb, Nahid ; Golshahi, Hannaneh</creatorcontrib><description>To evaluate the efficiency of Menstrual blood Stromal/Stem Cells (MenSCs) administration in Myocardial Infarction (MI), the effects of MenSCs and their derived conditioned Medium (CM) on cardiac function in MI rat model was assessed. Animals were divided into four groups including sham group, MI group, MenSCs derived CM group (CM group), and MenSCs suspended in CM (MenSCs+CM) group. The injection of different groups was carried out 30 after ligation of left anterior descending coronary artery into the infarct border zone. The results showed a significant reduction in scar size after injection of MenSCs+CM compared to MI group. Ejection fraction and fractional shortening of MenSCs+CM group were higher than CM and MI group at day 28. Administration of MenSCs+CM led to much more survival of cardiomyocytes, and prevention of meta-plastic development. Moreover, human mitochondrial transfer from MenSCs to cardiomyocytes was seen in group treated by MenSCs+CM. Indeed, MenSCs+CM treatment evoked nuclear factor-κB (NF-κB) down-regulation more than other treatments. MenSCs+CM treatment could significantly ameliorate cardiac function by different mechanisms including inhibition of cartilaginous metaplasia, inhibition of NF-κB and mitochondrial transfer.</description><identifier>ISSN: 2008-2835</identifier><identifier>EISSN: 2008-4625</identifier><identifier>DOI: 10.18502/ajmb.v15i3.12924</identifier><identifier>PMID: 37538240</identifier><language>eng</language><publisher>Iran: Avicenna Research Institute</publisher><subject>Original</subject><ispartof>Avicenna journal of medical biotechnology, 2023-07, Vol.15 (3), p.157-166</ispartof><rights>Copyright© 2023 Avicenna Research Institute.</rights><rights>Copyright© 2023 Avicenna Research Institute 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395459/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395459/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37538240$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Manshori, Mahmood</creatorcontrib><creatorcontrib>Kazemnejad, Somaieh</creatorcontrib><creatorcontrib>Naderi, Nasim</creatorcontrib><creatorcontrib>Shirazi, Abolfazl</creatorcontrib><creatorcontrib>Arabian, Maedeh</creatorcontrib><creatorcontrib>Eghtedar Doost, Marzieh</creatorcontrib><creatorcontrib>Darzi, Maryam</creatorcontrib><creatorcontrib>Montazeri, Samaneh</creatorcontrib><creatorcontrib>Aboutaleb, Nahid</creatorcontrib><creatorcontrib>Golshahi, Hannaneh</creatorcontrib><title>Higher Improvement of Cardiac Function Following Myocardial Infarction using Menstrual Blood Stromal/Stem Cells (MenSCs) Suspended in Conditioned Medium versus Conditioned Medium Alone in Rat Model</title><title>Avicenna journal of medical biotechnology</title><addtitle>Avicenna J Med Biotechnol</addtitle><description>To evaluate the efficiency of Menstrual blood Stromal/Stem Cells (MenSCs) administration in Myocardial Infarction (MI), the effects of MenSCs and their derived conditioned Medium (CM) on cardiac function in MI rat model was assessed. Animals were divided into four groups including sham group, MI group, MenSCs derived CM group (CM group), and MenSCs suspended in CM (MenSCs+CM) group. The injection of different groups was carried out 30 after ligation of left anterior descending coronary artery into the infarct border zone. The results showed a significant reduction in scar size after injection of MenSCs+CM compared to MI group. Ejection fraction and fractional shortening of MenSCs+CM group were higher than CM and MI group at day 28. Administration of MenSCs+CM led to much more survival of cardiomyocytes, and prevention of meta-plastic development. Moreover, human mitochondrial transfer from MenSCs to cardiomyocytes was seen in group treated by MenSCs+CM. Indeed, MenSCs+CM treatment evoked nuclear factor-κB (NF-κB) down-regulation more than other treatments. MenSCs+CM treatment could significantly ameliorate cardiac function by different mechanisms including inhibition of cartilaginous metaplasia, inhibition of NF-κB and mitochondrial transfer.</description><subject>Original</subject><issn>2008-2835</issn><issn>2008-4625</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNptUstqGzEUHUpLE9J8QDdFy3RhR895rEo61IkhJhC3a6HR3HEUNJIrzbjkA_NfkcdOaKHaSJfzkDg6WfaZ4DkpBaaX6rFv5jsiDJsTWlH-LjulGJcznlPx_nimJRMn2XmMj3i_CiwE-5idsEKwknJ8mj3fmM0DBLTst8HvoAc3IN-hWoXWKI0Wo9OD8Q4tvLX-j3EbtHryekItWrpOhQM-xgkDF4cwJui79b5F6yH4XtnL9QA9qsHaiC4SZ13Hr2g9xi24FlpkHKq9a83eKI0raM3Yox2EOMb_IVc2TXvVvRrQyrdgP2UfOmUjnB_3s-zX4sfP-mZ2e3e9rK9uZ5rmBZ8R1jR5RxXWGlOcEgBgtNJcV2XRFUQpXpIGNGVNJ1po8oaVHDqhlCbAeNOxs-zbwXc7Nj20OqUVlJXbYHoVnqRXRv6LOPMgN34nCWaV4KJKDhdHh-B_jxAH2ZuoUzLKgR-jpCXPK4Y5KROVHKg6-BgDdG_3ECynCsh9BeRUATlVIGm-_P3AN8Xrh7MXOUazew</recordid><startdate>202307</startdate><enddate>202307</enddate><creator>Manshori, Mahmood</creator><creator>Kazemnejad, Somaieh</creator><creator>Naderi, Nasim</creator><creator>Shirazi, Abolfazl</creator><creator>Arabian, Maedeh</creator><creator>Eghtedar Doost, Marzieh</creator><creator>Darzi, Maryam</creator><creator>Montazeri, Samaneh</creator><creator>Aboutaleb, Nahid</creator><creator>Golshahi, Hannaneh</creator><general>Avicenna Research Institute</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>202307</creationdate><title>Higher Improvement of Cardiac Function Following Myocardial Infarction using Menstrual Blood Stromal/Stem Cells (MenSCs) Suspended in Conditioned Medium versus Conditioned Medium Alone in Rat Model</title><author>Manshori, Mahmood ; Kazemnejad, Somaieh ; Naderi, Nasim ; Shirazi, Abolfazl ; Arabian, Maedeh ; Eghtedar Doost, Marzieh ; Darzi, Maryam ; Montazeri, Samaneh ; Aboutaleb, Nahid ; Golshahi, Hannaneh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2674-13bb6f2a0cc020382ee329c4c987f71aa481bec23bf5deb6b384ef5aac1e34bf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Original</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Manshori, Mahmood</creatorcontrib><creatorcontrib>Kazemnejad, Somaieh</creatorcontrib><creatorcontrib>Naderi, Nasim</creatorcontrib><creatorcontrib>Shirazi, Abolfazl</creatorcontrib><creatorcontrib>Arabian, Maedeh</creatorcontrib><creatorcontrib>Eghtedar Doost, Marzieh</creatorcontrib><creatorcontrib>Darzi, Maryam</creatorcontrib><creatorcontrib>Montazeri, Samaneh</creatorcontrib><creatorcontrib>Aboutaleb, Nahid</creatorcontrib><creatorcontrib>Golshahi, Hannaneh</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Avicenna journal of medical biotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Manshori, Mahmood</au><au>Kazemnejad, Somaieh</au><au>Naderi, Nasim</au><au>Shirazi, Abolfazl</au><au>Arabian, Maedeh</au><au>Eghtedar Doost, Marzieh</au><au>Darzi, Maryam</au><au>Montazeri, Samaneh</au><au>Aboutaleb, Nahid</au><au>Golshahi, Hannaneh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Higher Improvement of Cardiac Function Following Myocardial Infarction using Menstrual Blood Stromal/Stem Cells (MenSCs) Suspended in Conditioned Medium versus Conditioned Medium Alone in Rat Model</atitle><jtitle>Avicenna journal of medical biotechnology</jtitle><addtitle>Avicenna J Med Biotechnol</addtitle><date>2023-07</date><risdate>2023</risdate><volume>15</volume><issue>3</issue><spage>157</spage><epage>166</epage><pages>157-166</pages><issn>2008-2835</issn><eissn>2008-4625</eissn><abstract>To evaluate the efficiency of Menstrual blood Stromal/Stem Cells (MenSCs) administration in Myocardial Infarction (MI), the effects of MenSCs and their derived conditioned Medium (CM) on cardiac function in MI rat model was assessed. Animals were divided into four groups including sham group, MI group, MenSCs derived CM group (CM group), and MenSCs suspended in CM (MenSCs+CM) group. The injection of different groups was carried out 30 after ligation of left anterior descending coronary artery into the infarct border zone. The results showed a significant reduction in scar size after injection of MenSCs+CM compared to MI group. Ejection fraction and fractional shortening of MenSCs+CM group were higher than CM and MI group at day 28. Administration of MenSCs+CM led to much more survival of cardiomyocytes, and prevention of meta-plastic development. Moreover, human mitochondrial transfer from MenSCs to cardiomyocytes was seen in group treated by MenSCs+CM. Indeed, MenSCs+CM treatment evoked nuclear factor-κB (NF-κB) down-regulation more than other treatments. MenSCs+CM treatment could significantly ameliorate cardiac function by different mechanisms including inhibition of cartilaginous metaplasia, inhibition of NF-κB and mitochondrial transfer.</abstract><cop>Iran</cop><pub>Avicenna Research Institute</pub><pmid>37538240</pmid><doi>10.18502/ajmb.v15i3.12924</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2008-2835
ispartof Avicenna journal of medical biotechnology, 2023-07, Vol.15 (3), p.157-166
issn 2008-2835
2008-4625
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10395459
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access
subjects Original
title Higher Improvement of Cardiac Function Following Myocardial Infarction using Menstrual Blood Stromal/Stem Cells (MenSCs) Suspended in Conditioned Medium versus Conditioned Medium Alone in Rat Model
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T13%3A30%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Higher%20Improvement%20of%20Cardiac%20Function%20Following%20Myocardial%20Infarction%20using%20Menstrual%20Blood%20Stromal/Stem%20Cells%20(MenSCs)%20Suspended%20in%20Conditioned%20Medium%20versus%20Conditioned%20Medium%20Alone%20in%20Rat%20Model&rft.jtitle=Avicenna%20journal%20of%20medical%20biotechnology&rft.au=Manshori,%20Mahmood&rft.date=2023-07&rft.volume=15&rft.issue=3&rft.spage=157&rft.epage=166&rft.pages=157-166&rft.issn=2008-2835&rft.eissn=2008-4625&rft_id=info:doi/10.18502/ajmb.v15i3.12924&rft_dat=%3Cproquest_pubme%3E2846930418%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2846930418&rft_id=info:pmid/37538240&rfr_iscdi=true